BHC
NYSEBausch Health Companies Inc.
Price
Key statistics
Insider activity
SEC EDGAR ↗Showing 10 recent filings. None are open-market buys/sells — recent activity is grants, option exercises, gifts or tax withholding (which don't signal conviction).
| Insider | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|
Lenar Aimee J. President, US Pharma | Tax withholding | 5.26K | $4.83 | $25,405.80 | 2026-07-17 |
Lenar Aimee J. President, US Pharma | Tax withholding | 23.4K | $4.89 | $114,401.55 | 2026-07-15 |
LEE STEVEN HYOSIG SVP, Controller & CAO | Tax withholding | 3.13K | $4.75 | $14,843.75 | 2026-07-14 |
WECHSLER AMY B Director | Grant / award | 1.39K | $4.93 | $6,872.42 | 2026-06-30 |
Paulson John Director | Grant / award | 12.68K | $4.93 | $62,497.61 | 2026-06-30 |
LEUNG SANDRA Director | Grant / award | 6.85K | $4.93 | $33,745.85 | 2026-06-30 |
WECHSLER AMY B Director | Grant / award | 45.87K | $0.00 | — | 2026-05-22 |
ROBERTS EIRY Director | Grant / award | 45.87K | $0.00 | — | 2026-05-22 |
POWER ROBERT N Director | Grant / award | 45.87K | $0.00 | — | 2026-05-22 |
Paulson John Director | Grant / award | 45.87K | $0.00 | — | 2026-05-22 |
Source: SEC EDGAR Forms 4/4A (CIK 885590). Click an insider to open the original filing.
Social sentiment
Volume-weighted across live social sources
$BHC closed up 14% on Friday after also rallying 28.9% on Thursday post earnings. The very interesting part of this was Friday saw more volume than Thursday and both sessions the stock closed near the HOD. $BHC is a debt story... nearly $20BIL - but they have been deleveraging and also generate over $1BIL in FC, not to mention have that $6BIL $BLCO stake. One of these days this stock starts to re-rate. This could be the start of it... or it could be next week, next month, or next year. But once is starts, will be $20+(and likely much higher) one to watch this coming week for confirmation...
$BHC Any updates on progress of the avsorged DRRX Lasucosterol phase 3 trial?
$BHC Bausch Health continues restructuring operations while reducing debt. Improving profitability and balance sheet strength remain important recovery catalysts.
$BHC last time it had a double digit move was when Papa left the building, drunk and puked on their door step as a parting gift. What a botched mess over the last decade.
$BHC Bausch Health continues executing its balance sheet restructuring while focusing on pharmaceutical and healthcare operations. Debt reduction and operational improvements remain the primary catalysts for shareholder value.
$BHC it is undervalued based on http://Finpile.ai
$BHC botch health company?
$ZENA ZenaTech's DaaS Oil and Gas Business Enters a Strengthened Market with Higher Oil Prices and More Than US$500 Billion in Expected Canadian Energy Investment Over the Next Decade https://finance.yahoo.com/energy/articles/zenatechs-daas-oil-gas-business-120000908.html $BHC $NET
$BHC this is holding way too well to ignore
$BHC I can’t believe today’s volume was more than yesterday. Insane!!! 😳
$BHC Wow best two day price action in years. Sold half of my position for nice gain. Will still hold the other half for another couple of years!
$BHC is on fire after that Q2 beat and raised guidance We saw a massive 53.8% jump in just five days Options action is off the charts with 13.1x momentum and 30x volume growth Traders are piling into Aug/Sep $6-7 calls, betting on more upside in the next month or two But today’s 14% spike also brought in some heavy short-dated $7 put action with around 2,000 contracts Looks like some big players are hedging or maybe fading this move If you're jumping in now, be smart Avoid naked calls Stick to defined-risk plays or maybe wait for a pullback It's bullish but crowded Keep it tight
Latest news
Bausch Health (BHC) Rockets 28% as Q2 Turnaround Fuels Recovery Outlook
Sector Update: Healthcare Stocks Decline Late Afternoon
BHC Q2 Earnings Beat Estimates on Salix and Solta Growth, '26 View Raised
Bausch Health Companies Inc. Q2 2026 Earnings Call Summary
Bausch Health Cos Q2 Earnings Call Highlights
Bausch Health (BHC) Q2 Earnings and Revenues Beat Estimates
Bausch (BHC) Reports Q2 Earnings: What Key Metrics Have to Say
Bausch: Q2 Earnings Snapshot
Bausch Health Rises After Q2 Earnings, Revenue Beat Estimates
BAUSCH HEALTH ANNOUNCES SECOND QUARTER 2026 RESULTS, RAISES GUIDANCE
Get insider-buy alerts
Free weekly digest of the most notable SEC insider purchases — plus early access to real-time alerts on your watchlist.